Atopic Dermatitis (Atopic Eczema) Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Atopic Dermatitis (Atopic Eczema) Treatment Market by Drug type (Corticosteroids, Calcineurin Inhibitors, Immunosuppressants, Phosphodiesterase type 4 (PDE-4) Inhibitors, Antibiotics, Antihistamines, Emollients), Route of administration (Oral, Topical, Parenteral), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography (Latin America, North America, Asia Pacific, The Middle East and Africa and Europe)

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Atopic dermatitis is also known as atopic eczema. Atopic dermatitis is a type of inflammatory disease which is of unknown origin usually starts in early infancy, but also affects a major number of adults. Atopic dermatitis results in itchy, red, swollen and cracked skin. Many people with atopic dermatitis may develop hay fever and asthma. The causes are unknown but it is found to involve inherited, immune system dysfunction, environmental exposure and difficulties in permeability of skin. Multiple factors such as seasonal allergies, low humidity, exposure to harsh detergents & soaps, and cold weather can trigger or worsen atopic dermatitis, including. The atopic dermatitis treatment includes mainly steroid creams and moisturizers. Often, antibiotics are used when there is a skin infection. Diagnosis is done by physical examination and in some cases, biopsy is performed. Atopic Dermatitis Treatment aims to control inflammation and relieving itching. Atopic dermatitis treatment market is expected to grow at steady state during the forecast period. Market players are focusing on research and development to discover new drugs to treat atopic dermatitis. Several global and regional players competing for the market share. Companies adopting several strategies such as acquisitions, mergers and partnering with other players to withstand the competition and grow their market share. For instance, AstraZeneca has entered into an agreement with LEO Pharma A/S, for the global license to tralokinumab in skin diseases. Tralokinumab is a potential new medicine that is being developed in phase II clinical trials for the treatment of patients with atopic dermatitis. In December 2016, Novartis acquired UK based Ziarco Group and expanded its R&D portfolio with once daily oral H4 receptor agonist, ZPL389, that is being developed for the treatment of atopic dermatitis. In addition, new classes of products are launched targeting atopic dermatitis other than the traditional classes such as corticosteroids. This gives the health care professionals to choose various alternatives. For instance, in February 2017, Pfizer got FDA approval for Eucris, a non-steroidal topical phosphodiesterase-4 inhibitor that is used for treatment of mild to moderate atopic dermatitis.

Atopic Dermatitis (Atopic Eczema) Treatment Market

MARKET SUMMARY
-
x% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– x%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Atopic Dermatitis (Atopic Eczema) Treatment Market

  • The report on global heart valves market gives historical, current and future market sizes (US$ Bn) based on product type, valve type, harvesting, end users, and geographic regions.
  • heart valves market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Pfizer Inc.
  • Anacor Pharmaceutical Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi S.A.
  • Novartis AG
Atopic Dermatitis (Atopic Eczema) Treatment Market

Drivers And Restraints

Global Atopic Eczema treatment market is driven by increased R&D funding to develop biologics and development of targeted therapies for atopic dermatitis. In addition increased incidence of atopic dermatitis, new product launches, and increased awareness about the symptoms of atopic dermatitis expected to further boost the market. However, availability of the generic drugs and high cost of dermatology drugs are expected to hamper the market during the forecast period.


North-America got significant share

Atopic Dermatitis (Atopic Eczema) Treatment Market

Geographically atopic dermatitis treatment market has been segmented into following regions Viz. North America, Latin America, Asia Pacific, Europe, and Middle East and Africa. North America dominates the market, expected to show notable growth rates owing to product launches, lifestyle changes, and early treatment adoption. According to the national eczema association in the U.S., 31.6 million people are living with eczema. Europe atopic dermatitis market is growing due to large research and development activities. The Asia Pacific market is expected to grow at a higher rate owing to rapid population growth, availability of large patient pool and changing lifestyle.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments


Key

Report Outline

Atopic Dermatitis (Atopic Eczema) Treatment Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

1. Executive summary

2. Global Atopic Dermatitis Treatment Market Introduction
Global Atopic Dermatitis Treatment Market– Taxonomy
Global Atopic Dermatitis Treatment Market–Definitions
Drug Type
Route of Administration

3. Global Atopic Dermatitis Treatment Market Dynamics
Drivers
Restraints
Opportunities/Unmet Needs of the Market
Trends
Global Atopic Dermatitis Treatment Market Dynamics – Factors Impact Analysis
Global Atopic Dermatitis Treatment Market– Recent Market Introductions

4. Global Atopic Dermatitis Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%)
Market Oppurtunity Analysis

5. Global Atopic Dermatitis Treatment Market Forecast, By Drug Type, 2013 – 2017 and Forecast, 2018 – 2024
Corticosteroids Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
Calcineurin Inhibitors Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
Immunosuppressants Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
Phosphodiesterase type 4 (PDE-4) Inhibitors
Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
Antibiotics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
Antihistamines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
Emollients Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis

6. Global Atopic Dermatitis Treatment Market Forecast, By Route of Administration, 2013 – 2017 and Forecast, 2018 – 2024
Oral
Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
Topical Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
Parenteral Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis

7. Global Atopic Dermatitis Treatment Market Forecast, By Distribution Channel, 2013 – 2017 and Forecast, 2018 – 2024
Hospital Pharmacies Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
Retail Pharmacies Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
Online Pharmacies Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis

8. Global Atopic Dermatitis Treatment Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024
North America Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
Europe Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
Asia-Pacific Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
Latin America Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
Middle East and Africa Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
Global Atopic Dermatitis Treatment Market- Opportunity Analysis Index – By Route of Administration, By Drug Type, By Distribution Channel, and Region, 2018 – 2024

9. North America Atopic Dermatitis Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
Drug Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Corticosteroids
Calcineurin Inhibitors
Immunosuppressants
Phosphodiesterase type 4 (PDE-4) Inhibitors
Antibiotics
Antihistamines
Emollients
Route of Administration Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Oral
Topical
Parenteral
Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
North America Atopic Dermatitis Treatment Market- Opportunity Analysis Index – By Route of Administration, By Drug Type, By Distribution Channel, and Country, 2018 – 2024
North America Atopic Dermatitis Treatment Market Dynamics – Trends

10. Europe Atopic Dermatitis Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
Drug Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Corticosteroids
Calcineurin Inhibitors
Immunosuppressants
Phosphodiesterase type 4 (PDE-4) Inhibitors
Antibiotics
Antihistamines
Emollients
Route of Administration Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Oral
Topical
Parenteral
Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Germany
UK
France
Spain
Italy
Russia
Poland
Rest of Europe
Europe Atopic Dermatitis Treatment Market- Opportunity Analysis Index – By Route of Administration, By Drug Type, By Distribution Channel, and Country, 2018 – 2024
Europe Atopic Dermatitis Treatment Market Dynamics – Trends

11. Asia-Pacific Atopic Dermatitis Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
Drug Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Corticosteroids
Calcineurin Inhibitors
Immunosuppressants
Phosphodiesterase type 4 (PDE-4) Inhibitors
Antibiotics
Antihistamines
Emollients
Route of Administration Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Oral
Topical
Parenteral
Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn),

Y-o-Y Growth (%), and Market Share (%)
Japan
China
India
ASEAN
Australia & New Zealand
Rest of Asia-Pacific

Asia-Pacific Atopic Dermatitis Treatment Market- Opportunity Analysis Index – By Route of Administration, By Drug Type, By Distribution Channel, and Country, 2018 – 2024
Asia-Pacific Atopic Dermatitis Treatment Market Dynamics – Trends

12. Latin America Atopic Dermatitis Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
Drug Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Corticosteroids
Calcineurin Inhibitors
Immunosuppressants
Phosphodiesterase type 4 (PDE-4) Inhibitors
Antibiotics
Antihistamines
Emollients
Route of Administration Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Oral
Topical
Parenteral
Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Brazil
Mexico
Argentina
Venezuela
Rest of Latin America
Latin America Atopic Dermatitis Treatment Market- Opportunity Analysis Index – By Route of Administration, By Drug Type, By Distribution Channel, and Country, 2018 – 2024
Latin America Atopic Dermatitis Treatment Market Dynamics – Trends

13. Middle East & Africa Atopic Dermatitis Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
Drug Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Corticosteroids
Calcineurin Inhibitors
Immunosuppressants
Phosphodiesterase type 4 (PDE-4) Inhibitors
Antibiotics
Antihistamines
Emollients
Route of Administration Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Oral
Topical
Parenteral
Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
Gulf Cooperation Council (GCC) Countries
Israel
South Africa
Rest of MEA
MEA Atopic Dermatitis Treatment Market- Opportunity Analysis Index – By Route of Administration, By Drug Type, By Distribution Channel, and Country, 2018 – 2024
MEA Atopic Dermatitis Treatment Market Dynamics – Trends

14. Competition Landscape
Strategic Dashboard of Top Market Players
Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
Leo Pharma A/S (Denmark)
Nestlé S.A. (Galderma SA) (Switzerland)
Pfizer Inc. (U.S.)
Anacor Pharmaceutical Inc. (U.S.)
Regeneron Pharmaceuticals, Inc. (U.S)
Sanofi S.A. (France)
Novartis AG (Switzerland)
Bayer AG (Germany)
Mylan N.V. (Meda Pharmaceuticals) (U.S.)
Bristol-Myers Squibb (BMS) (U.S)
Allergan Plc. (Ireland)

15. Research Methodology
16. Key Assumptions and Acronyms


Report

Company Profile

  • Leo Pharma A/S (Denmark),
  • Velite Pharmaceutical (India),
  • Nestlé S.A. (Galderma SA) (Switzerland),
  • Pfizer Inc. (U.S.),
  • Anacor Pharmaceutical Inc. (U.S.),
  • Regeneron Pharmaceuticals, Inc. (U.S),
  • Sanofi S.A. (France),
  • Novartis AG (Switzerland),
  • Bayer AG (Germany),
  • Mylan N.V. (Meda Pharmaceuticals) (U.S.),
  • Bristol-Myers Squibb (BMS) (U.S), and
  • Allergan Plc. (Ireland)

Description

Atopic dermatitis is also known as atopic eczema. Atopic dermatitis is a type of inflammatory disease which is of unknown origin usually starts in early infancy, but also affects a major number of adults. Atopic dermatitis results in itchy, red, swollen and cracked skin. Many people with atopic dermatitis may develop hay fever and asthma. The causes are unknown but it is found to involve inherited, immune system dysfunction, environmental exposure and difficulties in permeability of skin. Multiple factors such as seasonal allergies, low humidity, exposure to harsh detergents & soaps, and cold weather can trigger or worsen atopic dermatitis, including. The atopic dermatitis treatment includes mainly steroid creams and moisturizers. Often, antibiotics are used when there is a skin infection. Diagnosis is done by physical examination and in some cases, biopsy is performed. Atopic Dermatitis Treatment aims to control inflammation and relieving itching. Atopic dermatitis treatment market is expected to grow at steady state during the forecast period. Market players are focusing on research and development to discover new drugs to treat atopic dermatitis. Several global and regional players competing for the market share. Companies adopting several strategies such as acquisitions, mergers and partnering with other players to withstand the competition and grow their market share. For instance, AstraZeneca has entered into an agreement with LEO Pharma A/S, for the global license to tralokinumab in skin diseases. Tralokinumab is a potential new medicine that is being developed in phase II clinical trials for the treatment of patients with atopic dermatitis. In December 2016, Novartis acquired UK based Ziarco Group and expanded its R&D portfolio with once daily oral H4 receptor agonist, ZPL389, that is being developed for the treatment of atopic dermatitis. In addition, new classes of products are launched targeting atopic dermatitis other than the traditional classes such as corticosteroids. This gives the health care professionals to choose various alternatives. For instance, in February 2017, Pfizer got FDA approval for Eucris, a non-steroidal topical phosphodiesterase-4 inhibitor that is used for treatment of mild to moderate atopic dermatitis.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX